Effect and safety of dual anti-human epidermal growth factor receptor 2 therapy compared to monotherapy in patients with human epidermal growth factor receptor 2-positive breast cancer: a systematic review

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Epidermal Growth ◽

Real World Study of Pyrotinib in Human Epidermal Growth Factor Receptor-2 (HER2) Positive Breast Cancer

Case Medical Research ◽

10.31525/ct1-nct04158505 ◽

2019 ◽

Author(s):

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Real World ◽

Growth Factor Receptor ◽

Her2 Positive ◽

Epidermal Growth ◽

Evaluating human epidermal growth factor receptor 2 roles in the efficacy of Tamoxifen treatment in breast cancer, a systematic review

Pharmacological Reports ◽

10.1007/s43440-021-00237-z ◽

2021 ◽

Author(s):

Sepideh Mansouri ◽

Parisa Mokhtari-Hesari ◽

Fatemeh Naghavi-al-Hosseini ◽

Seyed Afshin Seyednejad ◽

Keivan Majidzadeh-A ◽

...

Keyword(s):

Breast Cancer ◽

Systematic Review ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Tamoxifen Treatment ◽

Epidermal Growth

Looking Deep Into the Heterogeneity of Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Can We Understand It Better?

Journal of Clinical Oncology ◽

10.1200/jco.2015.64.7495 ◽

2016 ◽

Vol 34 (6) ◽

pp. 521-523 ◽

Cited By ~ 4

Author(s):

Sherene Loi ◽

Peter Savas

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Epidermal Growth ◽

A novel role of ADGRF1 (GPR110) in promoting cellular quiescence and chemoresistance in human epidermal growth factor receptor 2‐positive breast cancer

The FASEB Journal ◽

10.1096/fj.202100070r ◽

2021 ◽

Vol 35 (7) ◽

Author(s):

Noor Mazin Abdulkareem ◽

Raksha Bhat ◽

Lanfang Qin ◽

Suhas Vasaikar ◽

Ambily Gopinathan ◽

...

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Cellular Quiescence ◽

Epidermal Growth ◽

Combination Trastuzumab and Chemotherapy May Have a Role in Women With Small, Node-Negative, Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer

Journal of Clinical Oncology ◽

10.1200/jco.2014.58.2965 ◽

2015 ◽

Vol 33 (1) ◽

pp. 124-125 ◽

Cited By ~ 1

Author(s):

Heather L. McArthur ◽

Patrick G. Morris ◽

Clifford A. Hudis

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Node Negative ◽

Epidermal Growth ◽

Prevention of brain metastases in human epidermal growth factor receptor 2-positive breast cancer

Current Opinion in Oncology ◽

10.1097/cco.0000000000000682 ◽

2020 ◽

Vol Publish Ahead of Print ◽

Cited By ~ 1

Author(s):

Lauriane Eberst ◽

Caroline Bailleux ◽

Thomas Bachelot

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Brain Metastases ◽

Growth Factor Receptor ◽

Epidermal Growth ◽

Tailored duration of adjuvant trastuzumab for human epidermal growth factor receptor 2-positive breast cancer

npj Precision Oncology ◽

10.1038/s41698-020-00128-1 ◽

2020 ◽

Vol 4 (1) ◽

Author(s):

Ke-Da Yu ◽

Xin Wang ◽

Wan-Kun Chen ◽

Lei Fan ◽

Miao Mo ◽

...

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Adjuvant Trastuzumab ◽

Epidermal Growth ◽

Impact of clinicopathological characteristics on the efficacy of neoadjuvant therapy in patients with human epidermal growth factor receptor-2-positive breast cancer

International Journal of Cancer ◽

10.1002/ijc.31097 ◽

2017 ◽

Vol 142 (4) ◽

pp. 844-853 ◽

Cited By ~ 3

Author(s):

Bin Zhao ◽

Hong Zhao

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Neoadjuvant Therapy ◽

Growth Factor Receptor ◽

Clinicopathological Characteristics ◽

Epidermal Growth ◽

Abstract P5-08-08: A human epidermal growth factor receptor 3 (HER3)-binding nanoparticle targets and kills Herceptin®-resistant human epidermal growth factor receptor 2 (HER2)-positive breast cancer

10.1158/0008-5472.sabcs13-p5-08-08 ◽

2013 ◽

Cited By ~ 1

Author(s):

JD Sims ◽

M Taguaim ◽

C Hanson ◽

X Cui ◽

LK Medina-Kauwe

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Growth Factor Receptor ◽

Her2 Positive ◽

Her2 Positive Breast Cancer ◽

Epidermal Growth ◽

Safety and Tolerability of Docetaxel, Cyclophosphamide, and Trastuzumab Compared to Standard Trastuzumab-Based Chemotherapy Regimens for Early-Stage Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer

Journal of Breast Cancer ◽

10.4048/jbc.2014.17.4.356 ◽

2014 ◽

Vol 17 (4) ◽

pp. 356 ◽

Cited By ~ 3

Author(s):

Potjana Jitawatanarat ◽

Tracey L. O'Connor ◽

Ellen B. Kossoff ◽

Ellis G. Levine ◽

Kaweesak Chittawatanarat ◽

...

Keyword(s):

Breast Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Early Stage ◽

Growth Factor Receptor ◽

Epidermal Growth ◽